Ongphiphadhanakul, B <br/><br/>
Etidronate inhibits the thyroid hormone-induced bone loss in rats assessed by bone mineral density and messenger ribonucleic acid markers of osteoblast and osteoclast function.  [electronic resource] 

 -  Endocrinology  Dec 1993 
 - 2502-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0013-7227 
<br/><br/><label>Standard No.: </label>10.1210/endo.133.6.8243271  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Biomarkers<br/>Bone Density--drug effects<br/>Etidronic Acid--pharmacology<br/>Femur--metabolism<br/>Male<br/>Osteoblasts--metabolism<br/>Osteoclasts--metabolism<br/>Osteoporosis--chemically induced<br/>RNA, Messenger--metabolism<br/>RNA, Ribosomal, 28S--metabolism<br/>Rats<br/>Spine--metabolism<br/>Thyroxine--pharmacology